By Eleanor Whitfield
Former buy-side analyst. Leads the desk with a focus on global markets, macro flows and what moves portfolios.
Jefferies could get Q3 boost from dealmaking pickup, Oppenheimer says
Oppenheimer lifted its third-quarter investment banking outlook for Jefferies to $1.274 billion, citing firmer M&A and equity underwriting.
JPMorgan's $8 trillion wealth unit names new operations chief
Julie Harris will retire from JPMorgan's $8 trillion wealth unit in early 2027, with deputy Fred Crosnier taking over operations on January
Yeti sets 2030 targets: steady sales growth, $1.2-1.4B cash flow
Yeti laid out its long-term growth plan through 2030, targeting mid-to-high single-digit annual sales growth and $1.2-1.4 billion in cumulat
Beyond America: which global markets look cheap or pricey now
US stocks have been hitting headlines for looking pricey, but America isn't the only place to invest. We size up other major markets using t
EU asks China to cap hybrid exports or face new tariffs
The EU is asking China to voluntarily cap hybrid car exports to Europe, warning that tariffs could follow if no deal is reached. Chinese hyb
Softcat's $1.05B GDT Deal Aims to Boost US Enterprise Reach
Softcat is buying US-based GDT for $1.05 billion to strengthen its presence with American enterprise customers. The deal, funded by cash, ne
Zambia's KCM taps China for $498M copper plant to mine waste
Vedanta's KCM is building a $498 million plant in Zambia to recover copper from old mine waste. The project, backed by Chinese engineering f
BofA stays bullish on DSV's Schenker plan despite Road snags
Bank of America reaffirms its positive view on DSV, saying the freight forwarder can still integrate DB Schenker by end-2026 and hit its DKK
Generac shares jump 18% on $2.4B Amazon backup generator deal
Generac shares jumped nearly 18% after signing a long-term deal to deliver $2.4 billion of backup generators to Amazon data centers in 2027
RBC sees Stryker's growth reaccelerating by 2027 after rough 2026
Stryker's stock is down over 19% in 2026 after a cyberattack and weak orthopedics sales. RBC sees a better 2027 as hospital capital spending
Nexperia partners with Tata to shift chipmaking to India
Nexperia will produce and package power-control chips at Tata Electronics' Dholera and Jagiroad facilities. The deal marks a strategic shift
European ADRs climb 1.24% as biotech swings dominate trading
The S&P Europe Select ADR Index rose 1.24% late Thursday, with biotech stocks driving the action. Cellectis jumped 10.9% while Biodexa Pharm